Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
55 studies found for:    HIV and pre exposure prophylaxis | NIH, U.S. Fed
Show Display Options
Rank Status Study
1 Recruiting Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women Who Have Sex With Men
Condition: HIV Infections
Interventions: Drug: Cabotegravir tablets;   Drug: TDF/FTC tablets;   Drug: TDF/FTC placebo tablets;   Drug: CAB placebo tablets;   Drug: CAB LA;   Drug: Placebo for CAB LA
2 Completed Evaluating the Safety and Tolerability of Antiretroviral Drug Regimens Used as Pre-Exposure Prophylaxis to Prevent HIV Infection in At-Risk Men Who Have Sex With Men and in At-Risk Women
Condition: HIV Infection
Interventions: Drug: Maraviroc;   Drug: Emtricitabine;   Drug: Tenofovir disoproxil fumarate;   Other: Maraviroc placebo;   Other: Emtricitabine placebo;   Other: Tenofovir disoproxil fumarate placebo
3 Completed Evaluating the Acceptability, Safety, and Use of Daily Truvada Pre-Exposure Prophylaxis in Healthy, HIV-Uninfected Adolescents
Condition: HIV Infections
Intervention: Drug: Truvada
4 Recruiting Body Compartment PK for New HIV Pre-exposure Prophylaxis Modalities
Condition: HIV Infections
Interventions: Drug: Truvada;   Drug: Genvoya
5 Completed
Has Results
Assessment of Pre-Exposure Prophylaxis (PrEP) Administered at Sexually Transmitted Disease (STD) Clinics
Condition: HIV Infections
Intervention: Drug: FTC 200 mg/TDF 300 mg fixed-dose combination tablet
6 Unknown  An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis
Condition: HIV Infection
Interventions: Behavioral: 3MV;   Behavioral: PCC;   Drug: Emtricitabine/tenofovir (FTC/TDF (Truvada®))
7 Completed The ADAPT Study: Use of Emtricitabine and Tenofovir Disoproxil Fumarate for Pre-Exposure Prophylaxis (PrEP)
Condition: HIV Infections
Intervention: Drug: Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF)
8 Completed
Has Results
Pre-Exposure Prophylaxis in YMSM
Condition: HIV
Interventions: Drug: coformulated emtricitabine (FTC) and tenofovir disoproxil fumarate (TDF) as PrEP;   Drug: Placebo;   Behavioral: Many Men, Many Voices (3MV)
9 Recruiting Optimizing HIV PrEP Through Shared Decision Making
Condition: Pre-Exposure Prophylaxis
Intervention: Behavioral: PrEP Decision Aid
10 Completed Clinician Attitudes and Behaviors Regarding Use of Pre-Exposure Prophylaxis (PrEP) for Primary HIV Prevention
Condition: Clinician Attitudes About PrEP
Intervention:
11 Not yet recruiting Dyadic-Based Diagnosis, Care and Prevention for HIV Discordant Couples in Tanzania
Condition: HIV
Interventions: Behavioral: HIV Self-Testing;   Behavioral: Immediate Access to ART for HIV infected couple members;   Behavioral: Access to PrEP for HIV uninfected couple members
12 Active, not recruiting Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278LA, for Pre-Exposure Prophylaxis
Condition: Human Immunodeficiency Virus (HIV)
Interventions: Drug: Rilpivirine;   Drug: Placebo
13 Recruiting Effect of Social Media Support and Financial Incentives on PrEP Adherence
Condition: Pre-Exposure Prophylaxis
Interventions: Behavioral: Financial Incentive;   Behavioral: Social Media Group
14 Completed Factors Affecting PrEP Adherence
Condition: HIV Infection
Intervention: Drug: Emtricitabine/tenofovir disoproxil
15 Recruiting Safer Conception Intervention for HIV-1 Serodiscordant Couples
Conditions: HIV Seropositivity;   Pregnancy, High-Risk
Interventions: Drug: PrEP;   Behavioral: Counseling on timed condomless sex, ART and PrEP adherence
16 Completed Partners Demonstration Project of PrEP and ART
Condition: HIV Infection
Interventions: Drug: FTC-TDF PrEP;   Drug: ART
17 Recruiting Employing eSBI in HIV Testing for At-risk Youth
Conditions: HIV;   Substance Use
Interventions: Behavioral: Alcohol Use BI;   Behavioral: Nutrition Intervention
18 Recruiting Uptake and Adherence to Daily Oral PrEP as a Primary Prevention Strategy for Young African Women: A Vanguard Study
Condition: HIV
Intervention: Drug: Truvada
19 Completed PrEP, Lube, and the Rectal Mucosa in MSM at Risk of HIV
Condition: HIV
Interventions: Drug: Truvada;   Device: Gel lubricant
20 Completed Self-Consent for PrEP Perspectives
Conditions: HIV;   PrEP
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.